Oral Microbiome Dysbiosis and Precancerous Lesions of the Upper GI Tract
The study highlights the relationship between oral microbiome dysbiosis and the development of precancerous lesions in the upper gastrointestinal (GI) tract. Dysbiosis refers to an imbalance in the microbial community, and in this context, it is associated with various upper GI disorders that may precede cancer, such as reflux, esophagitis, Barrett’s esophagus, and gastric conditions like atrophic gastritis.
Key Findings:
- Salivary Dysbiosis:
- Imbalances in the salivary microbiome were linked to conditions such as reflux, esophagitis, Barrett’s esophagus, and other gastric disorders.
- Saliva serves as a general indicator of systemic and upper GI health.
- Site-Specific Dysbiosis:
- Dysbiosis in the subgingival (below the gumline) and buccal mucosal (inner cheek) microbiomes was more specifically associated with Barrett’s esophagus and atrophic gastritis.
- These site-specific microbial changes suggest that the oral microbiome's composition varies depending on the disease and its location.
- Microbial Signatures:
- Disease states were characterized by an enrichment of harmful bacteria like Prevotella, Fusobacterium, and Fretibacterium.
- There was also a depletion of protective bacteria such as Haemophilus, which are thought to contribute to maintaining oral and systemic health.
- Cancer Risk Prediction:
- Among the oral microbiomes studied, the subgingival microbiota demonstrated the greatest potential as a biomarker for predicting cancer risk.
- This suggests that microbial imbalances in subgingival sites might be early indicators of esophageal and gastric cancer development.
Implications:
- Non-Invasive Biomarkers: The findings support the development of non-invasive diagnostic tools based on oral microbiome analysis. This could enable early detection of esophageal and gastric cancers, improving patient outcomes.
- Targeted Interventions: Understanding the specific microbial changes associated with different precancerous lesions may allow for targeted prevention strategies, such as microbiome modulation through probiotics, oral hygiene practices, or dietary changes.
Conclusion:
The study underscores the importance of the oral microbiome in the pathogenesis of upper GI tract disorders and its potential role in cancer risk assessment. Site-specific dysbiosis, particularly in the subgingival microbiota, offers promising avenues for developing early detection methods and preventive measures for esophageal and gastric cancers.
